Dr. Nicholas G. Melillo, M.D. Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 106 James St, Edison, NJ 08820 Phone: 732-906-0091 Fax: 732-906-0249 |
Dr. Madho K Sharma, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 974 Inman Ave Ste 1a, Edison, NJ 08820 Phone: 908-561-0183 Fax: 732-225-2814 |
Dr. Daniel E Rosenblatt, Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-321-7660 |
Vijaya Tirunahari, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 State Route 27, Suite 301, Edison, NJ 08820 Phone: 732-549-7380 Fax: 732-548-8216 |
News Archive
A substantial proportion of NK/T-cell lymphomas harbor Janus Kinase 3 gene mutations. Patients with these lymphomas might benefit from treatment with a Janus Kinase inhibitor according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
For some people suffering from chronic pain, part of their daily routine is recording the extent of it in a pain diary. Often done at the request of their physician or therapist, patients may be asked to record how severe the pain is, how it affects daily activities and which treatments ease it or make it worse.
A study conducted by researchers at Johann Wolfgang Goethe University in Frankfurt, Germany found that high doses of ursodeoxycholic acid, suggested by some studies to have a beneficial effect on nonalcoholic steatohepatitis, does not improve overall histology in these patients. Full findings of this study are published in the August issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.
BMI and waist circumference explain one half of all fatal and one quarter of all non-fatal cardiovascular disease in those overweight and obese in ten-year follow-up study
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun.
› Verified 1 days ago